Sanofi lowers Lantus insulin costs by 78% in U.S. market
Sanofi, a French pharmaceutical major, announced it would slash the price of insulin, Lantus, by 78% for all U.S. patients with commercial insurance.
Drugs
Medical
Pharma
Drugs
Medical
Pharma
Glenmark gets FDA nod for trials in US on tumour, cancer patients
Glenmark Specialty SA, a subsidiary of India’s Glenmark Pharmaceuticals, has got investigational new drug clearance from the FDA to conduct clinical trials in
Medical
Pharma
Mediar bags $105 mn from big pharmas to pursue fibrosis treatments
Mediar Therapeutics gets $105 million financing from Novartis, Pfizer, Eli Lilly and Bristol Myers to advance portfolio of first-in-class fibrosis therapies.
Drugs
Pharma
Dr. Reddy divests dermatology brands to Eris for INR 2.7b
India's Dr. Reddy's Laboratories has divested "certain" non-core dermatology brands of the company to Eris Lifesciences for INR 2.7 billion.
Drugs
Pharma
Janssen’s human trials for dengue virus to advance to phase II
Janssen Pharmaceutical Companies, a wholly-owned subsidiary of Johnson & Johnson, announced its first-in-human clinical trial of a compound to treat dengue had entered
Health
Medical
Pharma
Fifty-five nations facing a shortage of health workers: WHO
he WHO has identified 55 nations vulnerable to a shortfall in health workers needed to fulfil the UN’s charter for universal health coverage
Drugs
Medical
Pharma
FDA nod for Pfizer-Biotech vaccine booster for children
The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four
Drugs
Pharma
Novo Nordisk follows Eli Lilly on insulin price cuts
Denmark's Novo Nordisk plans to effect a 75% cut in insulin prices in the U.S. market by January 1, 2024.
Drugs
Medical
Pharma
Sanofi acquires Provention Bio for $2.9 billion to boost its diabetes portfolio
Sanofi acquires Provention Bio, and its TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D).
Drugs
Health
Medical
Leukaemia drug effective in treating breast cancer metastatic relapse
A mice study showed promising results in treating secondary recurrence of breast cancer in lungs